whatever that price may be. But with a PE of 17 and forward about 10 I gotta think it should be higher than where we are now.
along with all the other biotechs. I am convinced that the inclusion in an index last year is responsible for all of this. The IBB is down over 20% unfortunately we are down 40%...but that is the risk associated with small companies even though the outlook might be good. I think the lowered forward guidance also was a disappointment because it appears they are not as confident about getting approvals and making the product available in the marketplace. Now all that means is we are pushed out a little further until these prodcuts in the pipeline are delivered.
well now we know why the move lower yesterday...my question was answered....Collecting Shares...because of the announcement this morning.... this one is only 17 million but i'm hoping this gives more indication that FDA is moving faster with the new ANDA programs...also the reason why the company cancelled several older submissions to redo them for this current stage.
i was simply asking a question for a move to 5.75 which breaks support at 6....i am well aware of this companys prospects but this IS a high risk should any of these things not comeabout or the conversion is not as expected. Heavily shorted so i guess not everyone feels that way....stop telling other people what to do
and complete the buyout ..........I cant believe there are many shares left to buy as I would assume they should have been doing that when it was in the 40's of course why pay 68 when you can pay 40's
thinly traded can be moved around quite a bit...part of an index may be causing this...now hard to borrow...with all of these good news can't come fast enough...even though FDA program appears to be working faster...must convert approvals into revenues....high risk ...